1. Biological product deviation reporting for blood and plasma establishments Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, March 2020 Subject(s): Biological ProductsBlood Banks -- standardsMandatory ReportingUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, September 2019 Subject(s): Bacteriological TechniquesBlood Banks -- standardsBlood Platelets -- microbiologyBlood Preservation -- standardsPlatelet Transfusion -- standardsTransfusion Reaction -- prevention & controlProduct Labeling -- standardsQuality ControlHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Further testing of donations that are reactive on a licensed donor screening test for antibodies to hepatitis C virus Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2019 Subject(s): Blood -- virologyBlood Banks -- standardsBlood DonorsHepatitis C -- bloodHepatitis C -- transmissionDonor SelectionHepatitis C Antibodies -- bloodNucleic Acid Amplification TechniquesHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
